Skip to content

JBIO JBIO Acquisitions of property and equipment included in liabilities

Acquisitions of property and equipment included in liabilities at other companies

Karman Holdings Inc. logo
Karman Holdings Inc.KRMN
$2.32M+126%
NovoCure logo
NovoCureNVCR
$792K+213%
Astrana Health logo
Astrana HealthASTH
$0-100%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$104K
Lyft, Inc. logo
Lyft, Inc.LYFT
$36.74M+4,968%
Mid Penn Bancorp logo
Mid Penn BancorpMPB
$756.79M

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.33B
Enterprise value$1.28B

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1.

The official record: JBIO’s 10-K, filed March 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's acquisitions of property and equipment included in liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JBIO's acquisitions of property and equipment included in liabilities?
JBIO (JBIO) reported acquisitions of property and equipment included in liabilities of $104K in Q4 2025.
What does acquisitions of property and equipment included in liabilities mean?
Represents the total value of property, plant, and equipment acquired through non-cash transactions or arrangements where payment is deferred. This metric highlights capital expenditures that do not immediately impact cash flow from investing activities. It is essential for understanding the full scope of asset expansion beyond direct cash outlays.